Other studies report that resveratrol reduces inflammation in patients with UC to improve their quality of life and disease clinical colitis activity [36], and in animal models of IBD [14, 37], where there are reduced pro-inflammatory markers (TNF-α, IFN-γ, IL-1β, IL-6, and IL-4) and DAI. Here, IL1B is linked to inflammatory bowel disease.